|
|
| | BI 4464) Basic information |
| Product Name: | BI 4464) | | Synonyms: | Benzamide, 4-[[4-[(2,3-dihydro-3-oxo-1H-inden-4-yl)oxy]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-;BI-4464
(BI4464;BI 4464);Target Protein-binding Moiety,Inhibitor,BI 4464,Focal adhesion kinase,BI-4464,BI4464,inhibit,PTK2 protein tyrosine kinase 2,Ligands for Target Protein for PROTAC,PTK2,FAK;3-Methoxy-N-(1-methylpiperidin-4-yl)-4-((4-((3-oxo-2,3-dihydro-1H-inden-4-yl)oxy)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide | | CAS: | 1227948-02-8 | | MF: | C28H28F3N5O4 | | MW: | 555.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1227948-02-8.mol |  |
| | BI 4464) Chemical Properties |
| density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 16.67 mg/mL (30.01 mM) | | pka | 14.06±0.20(Predicted) |
| | BI 4464) Usage And Synthesis |
| Uses | BI-4464 FAK Inhibitor is used in the preparation of pyrimidinamine derivatives for treating diseases characterized by excessive or abnormal cell proliferation. |
| | BI 4464) Preparation Products And Raw materials |
|